1–8 of 8 results for pandemic
Expert Panel: Choroidal Melanoma
Basil K Williams, MD
Olufemi E Adams, M.D.
Jared T Sokol, MD, MBA
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2024
Factors Associated With COVID-19 Vaccine Hesitancy and Clinical Trends in the Presentation of Primary Rhegmatogenous Retinal Detachments
Peter H. Tang, MD, PhD
2022
The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections
Kapil Mishra, MD
On Demand Cases, Courses, and Papers
2021
Barriers to Follow-up Retinal Care During the COVID-19 Pandemic: A Survey Study
Michael A Klufas, MD
The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During the COVID-19 Pandemic
Sunir J. Garg, MD, FACS, FASRS
Impact of the COVID-19 Pandemic on Characteristics of Retinal Detachments: The Canadian Experience
Parnian Arjmand, MD, MSc, FRCSC, DABO
Comparison of Tumor Size at Presentation and Genomics in Uveal Melanoma Patients Before and After the COVID-19 Pandemic
Amy C. Schefler, MD FACS FASRS
Quality of Life and Retinal Disease During the COVID-19 Pandemic
Peter Y Zhao, MD